The vaccine will come with a warning about a risk of rare blood clots in recipients. The move by the Centers for Disease Control and Prevention and the Food and Drug Administration, which means vaccinations could resume as early as Saturday, followed a daylong safety review of the vaccine by a CDC advisory panel. |
No comments:
Post a Comment